{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T18:14:53Z","timestamp":1775240093194,"version":"3.50.1"},"reference-count":64,"publisher":"American Society of Hematology","issue":"8","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2004,4,15]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>If present in sufficient numbers, could extrathymic T cells substitute for thymus-derived T cells? To address this issue, we studied extrathymic T cells that develop in athymic mice under the influence of oncostatin M (OM). In this model, extensive T-cell development is probably due to amplification of a minor pathway of T-cell differentiation taking place only in the lymph nodes. Extrathymic CD4 T cells expanded poorly and were deficient in providing B-cell help after infection with vesicular stomatitis virus (VSV) and lymphocytic choriomeningitis virus (LCMV). Compared with classic T cells, stimulated extrathymic CD8 T cells produced copious amounts of interferon \u03b3 (IFN-\u03b3), and their expansion was precocious but of limited amplitude because of a high apoptosis rate. Consequently, although extrathymic cytotoxic T lymphocytes (CTLs) responded to LCMV infection, as evidenced by the expansion of GP33-41 tetramer-positive CD8 T cells, they were unable to eradicate the virus. Our data indicate that the site of development impinges on T-cell quality and function and that extrathymic T cells functionally cannot substitute for classical thymic T cells. (Blood. 2004;103:3102-3110)<\/jats:p>","DOI":"10.1182\/blood-2003-09-3311","type":"journal-article","created":{"date-parts":[[2003,12,30]],"date-time":"2003-12-30T01:13:55Z","timestamp":1072746835000},"page":"3102-3110","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":22,"title":["Do thymically and strictly extrathymically developing T cells generate similar immune responses?"],"prefix":"10.1182","volume":"103","author":[{"given":"Marie-E\u0300ve","family":"Blais","sequence":"first","affiliation":[{"name":"From the Guy-Bernier Research Center, Maisonneuve-Rosemont Hospital, Montreal, QC, Canada; and Institute for Experimental Immunology, University Hospital, Zu\u0308rich, Switzerland."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gwladys","family":"Ge\u0301rard","sequence":"additional","affiliation":[{"name":"From the Guy-Bernier Research Center, Maisonneuve-Rosemont Hospital, Montreal, QC, Canada; and Institute for Experimental Immunology, University Hospital, Zu\u0308rich, Switzerland."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marianne M.","family":"Martinic","sequence":"additional","affiliation":[{"name":"From the Guy-Bernier Research Center, Maisonneuve-Rosemont Hospital, Montreal, QC, Canada; and Institute for Experimental Immunology, University Hospital, Zu\u0308rich, Switzerland."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guillaume","family":"Roy-Proulx","sequence":"additional","affiliation":[{"name":"From the Guy-Bernier Research Center, Maisonneuve-Rosemont Hospital, Montreal, QC, Canada; and Institute for Experimental Immunology, University Hospital, Zu\u0308rich, Switzerland."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rolf M.","family":"Zinkernagel","sequence":"additional","affiliation":[{"name":"From the Guy-Bernier Research Center, Maisonneuve-Rosemont Hospital, Montreal, QC, Canada; and Institute for Experimental Immunology, University Hospital, Zu\u0308rich, Switzerland."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claude","family":"Perreault","sequence":"additional","affiliation":[{"name":"From the Guy-Bernier Research Center, Maisonneuve-Rosemont Hospital, Montreal, QC, Canada; and Institute for Experimental Immunology, University Hospital, Zu\u0308rich, Switzerland."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"234","reference":[{"key":"2020021222024296900_REF1","doi-asserted-by":"crossref","unstructured":"Zapata A, Amemiya CT. Phylogeny of lower vertebrates and their immunological structures. Curr Top Microbiol Immunol.2000;248: 67-107.","DOI":"10.1007\/978-3-642-59674-2_5"},{"key":"2020021222024296900_REF2","doi-asserted-by":"crossref","unstructured":"Anderson G, Moore NC, Owen JJ, Jenkinson EJ. Cellular interactions in thymocyte development. Annu Rev Immunol.1996;14: 73-99.","DOI":"10.1146\/annurev.immunol.14.1.73"},{"key":"2020021222024296900_REF3","doi-asserted-by":"crossref","unstructured":"Anderson G, Harman BC, Hare KJ, Jenkinson EJ. Microenvironmental regulation of T cell development in the thymus. Semin Immunol.2000;12: 457-464.","DOI":"10.1006\/smim.2000.0260"},{"key":"2020021222024296900_REF4","doi-asserted-by":"crossref","unstructured":"Anderson G, Jenkinson EJ. Lymphostromal interactions in thymic development and function. Nat Rev Immunol.2001;1: 31-40.","DOI":"10.1038\/35095500"},{"key":"2020021222024296900_REF5","doi-asserted-by":"crossref","unstructured":"Zinkernagel RM, Althage A. On the role of thymic epithelium vs. bone marrow-derived cells in repertoire selection of T cells. Proc Natl Acad Sci U S A.1999;96: 8092-8097.","DOI":"10.1073\/pnas.96.14.8092"},{"key":"2020021222024296900_REF6","doi-asserted-by":"crossref","unstructured":"Anderson G, Jenkinson EJ, Moore NC, Owen JJ. MHC class II-positive epithelium and mesenchyme cells are both required for T-cell development in the thymus. Nature.1993;362: 70-73.","DOI":"10.1038\/362070a0"},{"key":"2020021222024296900_REF7","doi-asserted-by":"crossref","unstructured":"Suniara RK, Jenkinson EJ, Owen JJT. An essential role for thymic mesenchyme in early T cell development. J Exp Med.2000;191: 1051-1056.","DOI":"10.1084\/jem.191.6.1051"},{"key":"2020021222024296900_REF8","doi-asserted-by":"crossref","unstructured":"Anderson G, Hare KJ, Jenkinson EJ. Positive selection of thymocytes: the long and winding road. Immunol Today.1999;20: 463-468.","DOI":"10.1016\/S0167-5699(99)01524-8"},{"key":"2020021222024296900_REF9","doi-asserted-by":"crossref","unstructured":"Carlyle JR, Zuniga-Pflu\u0308cker JC. Requirement for the thymus in \u03b1\u03b2 T lymphocyte lineage commitment. Immunity.1998;9: 187-197.","DOI":"10.1016\/S1074-7613(00)80601-9"},{"key":"2020021222024296900_REF10","doi-asserted-by":"crossref","unstructured":"Zinkernagel RM, Althage A, Waterfield E, et al. Restriction specificities, alloreactivity, and allotolerance expressed by T cells from nude mice reconstituted with H-2-compatible or -incompatible thymus grafts. J Exp Med.1980;151: 376-399.","DOI":"10.1084\/jem.151.2.376"},{"key":"2020021222024296900_REF11","doi-asserted-by":"crossref","unstructured":"Zerrahn J, Volkmann A, Coles MC, et al. Class I molecules on hematopoietic cells can support intrathymic positive selection of T cell receptor transgenic T cells. Proc Natl Acad Sci U S A.1999;96: 11470-11475.","DOI":"10.1073\/pnas.96.20.11470"},{"key":"2020021222024296900_REF12","doi-asserted-by":"crossref","unstructured":"Martinic MM, Rulicke T, Althage A, et al. Efficient T cell repertoire selection in tetraparental chimeric mice independent of thymic epithelial MHC. Proc Natl Acad Sci U S A.2003;100: 1861-1866.","DOI":"10.1073\/pnas.252641399"},{"key":"2020021222024296900_REF13","doi-asserted-by":"crossref","unstructured":"Coles MC, Raulet DH. NK1.1+ T cells in the liver arise in the thymus and are selected by interactions with class I molecules on CD4+CD8+ cells. J Immunol.2000;164: 2412-2418.","DOI":"10.4049\/jimmunol.164.5.2412"},{"key":"2020021222024296900_REF14","doi-asserted-by":"crossref","unstructured":"Urdahl KB, Sun JC, Bevan MJ. Positive selection of MHC class Ib restricted CD8+ T cells on hematopoietic cells. Nat Immunol.2002;3: 772-779.","DOI":"10.1038\/ni814"},{"key":"2020021222024296900_REF15","doi-asserted-by":"crossref","unstructured":"Sullivan BA, Kraj P, Weber DA, Ignatowicz L, Jensen PE. Positive selection of a Qa-1-restricted T cell receptor with specificity for insulin. Immunity.2002;17: 95-105.","DOI":"10.1016\/S1074-7613(02)00343-6"},{"key":"2020021222024296900_REF16","doi-asserted-by":"crossref","unstructured":"Tanchot C, Lemonnier FA, Perarnau B, Freitas AA, Rocha B. Differential requirements for survival and proliferation of CD8 naive or memory T cells. Science.1997;276: 2057-2062.","DOI":"10.1126\/science.276.5321.2057"},{"key":"2020021222024296900_REF17","doi-asserted-by":"crossref","unstructured":"Clegg CH, Rulffes JT, Wallace PM, Haugen HS. Regulation of an extrathymic T-cell development pathway by oncostatin M. Nature.1996;384: 261-263.","DOI":"10.1038\/384261a0"},{"key":"2020021222024296900_REF18","doi-asserted-by":"crossref","unstructured":"Boileau C, Houde M, Dulude G, Clegg CH, Perreault C. Regulation of extrathymic T cell development and turnover by oncostatin M. J Immunol.2000;164: 5713-5720.","DOI":"10.4049\/jimmunol.164.11.5713"},{"key":"2020021222024296900_REF19","doi-asserted-by":"crossref","unstructured":"Guy-Grand D, Azogui O, Celli S, et al. Extrathymic T cell lymphopoiesis: ontogeny and contribution to gut intraepithelial lymphocytes in athymic and euthymic mice. J Exp Med.2003;197: 333-341.","DOI":"10.1084\/jem.20021639"},{"key":"2020021222024296900_REF20","doi-asserted-by":"crossref","unstructured":"Louis I, Dulude G, Corneau S, et al. Changes in the lymph node microenvironment induced by oncostatin M. Blood.2003;102: 1397-1404.","DOI":"10.1182\/blood-2003-01-0316"},{"key":"2020021222024296900_REF21","doi-asserted-by":"crossref","unstructured":"Terra R, Labrecque N, Perreault C. Thymic and extrathymic T cell development pathways follow different rules. J Immunol.2002;169: 684-692.","DOI":"10.4049\/jimmunol.169.2.684"},{"key":"2020021222024296900_REF22","doi-asserted-by":"crossref","unstructured":"Clegg CH, Haugen HS, Rulffes JT, Friend SL, Farr AG. Oncostatin M transforms lymphoid tissue function in transgenic mice by stimulating lymph node T-cell development and thymus autoantibody production. Exp Hematol.1999;27: 712-725.","DOI":"10.1016\/S0301-472X(98)00084-8"},{"key":"2020021222024296900_REF23","doi-asserted-by":"crossref","unstructured":"Lyons AB, Parish CR. Determination of lymphocyte division by flow cytometry. J Immunol Methods.1994;171: 131-137.","DOI":"10.1016\/0022-1759(94)90236-4"},{"key":"2020021222024296900_REF24","doi-asserted-by":"crossref","unstructured":"Gudmundsdottir H, Wells AD, Turka LA. Dynamics and requirements of T cell clonal expansion in vivo at the single-cell level: effector function is linked to proliferative capacity. J Immunol.1999;162: 5212-5223.","DOI":"10.4049\/jimmunol.162.9.5212"},{"key":"2020021222024296900_REF25","doi-asserted-by":"crossref","unstructured":"Planz O, Ehl S, Furrer E, et al. A critical role for neutralizing-antibody-producing B cells, CD4+ T cells, and interferons in persistent and acute infections of mice with lymphocytic choriomeningitis virus: implications for adoptive immunotherapy of virus carriers. Proc Natl Acad Sci U S A.1997;94: 6874-6879.","DOI":"10.1073\/pnas.94.13.6874"},{"key":"2020021222024296900_REF26","doi-asserted-by":"crossref","unstructured":"Gallimore A, Glithero A, Godkin A, et al. Induction and exhaustion of lymphocytic choriomeningitis virus-specific cytotoxic T lymphocytes visualized using soluble tetrameric major histocompatibility complex class I-peptide complexes. J Exp Med.1998;187: 1383-1393.","DOI":"10.1084\/jem.187.9.1383"},{"key":"2020021222024296900_REF27","doi-asserted-by":"crossref","unstructured":"Ochsenbein AF, Pinschewer DD, Odermatt B, et al. Protective T cell-independent antiviral antibody responses are dependent on complement. J Exp Med.1999;190: 1165-1174.","DOI":"10.1084\/jem.190.8.1165"},{"key":"2020021222024296900_REF28","doi-asserted-by":"crossref","unstructured":"Battegay M, Cooper S, Althage A, et al. Quantification of lymphocytic choriomeningitis virus with an immunological focus assay in 24- or 96-well plates [published errata appear in J Virol Methods 1991 Nov;35(1):115 and 1992 Aug;38(2):263]. J Virol Methods.1991;33: 191-198.","DOI":"10.1016\/0166-0934(91)90018-U"},{"key":"2020021222024296900_REF29","doi-asserted-by":"crossref","unstructured":"Ochsenbein AF, Pinschewer DD, Odermatt B, et al. Correlation of T cell independence of antibody responses with antigen dose reaching secondary lymphoid organs: implications for splenectomized patients and vaccine design. J Immunol.2000;164: 6296-6302.","DOI":"10.4049\/jimmunol.164.12.6296"},{"key":"2020021222024296900_REF30","doi-asserted-by":"crossref","unstructured":"Charan S, Zinkernagel RM. Antibody mediated suppression of secondary IgM response in nude mice against vesicular stomatitis virus. J Immunol.1986;136: 3057-3061.","DOI":"10.4049\/jimmunol.136.8.3057"},{"key":"2020021222024296900_REF31","doi-asserted-by":"crossref","unstructured":"Fontaine P, Roy-Proulx G, Knafo L, et al. Adoptive transfer of T lymphocytes targeted to a single immunodominant minor histocompatibility antigen eradicates leukemia cells without causing graft-versus-host disease. Nat Med.2001;7: 789-794.","DOI":"10.1038\/89907"},{"key":"2020021222024296900_REF32","doi-asserted-by":"crossref","unstructured":"McBride K, Baron C, Picard S, et al. The model B6dom1 minor histocompatibility antigen is encoded by a mouse homolog of the yeast STT3 gene. Immunogenetics.2002;54: 562-569.","DOI":"10.1007\/s00251-002-0502-4"},{"key":"2020021222024296900_REF33","doi-asserted-by":"crossref","unstructured":"Ludewig B, Ehl S, Karrer U, et al. Dendritic cells efficiently induce protective antiviral immunity. J Virol.1998;72: 3812-3818.","DOI":"10.1128\/JVI.72.5.3812-3818.1998"},{"key":"2020021222024296900_REF34","doi-asserted-by":"crossref","unstructured":"Coles RM, Mueller SN, Heath WR, Carbone FR, Brooks AG. Progression of armed CTL from draining lymph node to spleen shortly after localized infection with herpes simplex virus 1. J Immunol.2002;168: 834-838.","DOI":"10.4049\/jimmunol.168.2.834"},{"key":"2020021222024296900_REF35","doi-asserted-by":"crossref","unstructured":"Zinkernagel RM, Welsh RM. H-2 compatibility requirement for virus-specific T cell-mediated effector functions in vivo; I: specificity of T cells conferring antiviral protection against lymphocytic choriomeningitis virus is associated with H-2K and H-2D. J Immunol.1976;117: 1495-1502.","DOI":"10.4049\/jimmunol.117.5_Part_1.1495"},{"key":"2020021222024296900_REF36","doi-asserted-by":"crossref","unstructured":"Byrne JA, Oldstone MB. Biology of cloned cytotoxic T lymphocytes specific for lymphocytic choriomeningitis virus: clearance of virus in vivo. J Virol.1984;51: 682-686.","DOI":"10.1128\/JVI.51.3.682-686.1984"},{"key":"2020021222024296900_REF37","doi-asserted-by":"crossref","unstructured":"Thomsen AR, Johansen J, Marker O, Christensen JP. Exhaustion of CTL memory and recrudescence of viremia in lymphocytic choriomeningitis virus-infected MHC class II-deficient mice and B cell-deficient mice. J Immunol.1996;157: 3074-3080.","DOI":"10.4049\/jimmunol.157.7.3074"},{"key":"2020021222024296900_REF38","doi-asserted-by":"crossref","unstructured":"Charan S, Huegin AW, Cerny A, Hengartner H, Zinkernagel RM. Effects of cyclosporin A on humoral immune response and resistance against vesicular stomatitis virus in mice. J Virol.1986;57: 1139-1144.","DOI":"10.1128\/JVI.57.3.1139-1144.1986"},{"key":"2020021222024296900_REF39","doi-asserted-by":"crossref","unstructured":"Lefrancois L. Protection against lethal viral infection by neutralizing and nonneutralizing monoclonal antibodies: distinct mechanisms of action in vivo. J Virol.1984;51: 208-214.","DOI":"10.1128\/JVI.51.1.208-214.1984"},{"key":"2020021222024296900_REF40","doi-asserted-by":"crossref","unstructured":"Moskophidis D, Battegay M, Bruendler MA, et al. Resistance of lymphocytic choriomeningitis virus to \u03b1\u03b2 interferon and to \u03b3 interferon. J Virol.1994;68: 1951-1955.","DOI":"10.1128\/JVI.68.3.1951-1955.1994"},{"key":"2020021222024296900_REF41","doi-asserted-by":"crossref","unstructured":"Karrer U, Althage A, Odermatt B, et al. On the key role of secondary lymphoid organs in antiviral immune responses studied in alymphoplastic (aly\/aly) and spleenless (Hox11-\/-) mutant mice. J Exp Med.1997;185: 2157-2170.","DOI":"10.1084\/jem.185.12.2157"},{"key":"2020021222024296900_REF42","doi-asserted-by":"crossref","unstructured":"Ehl S, Klenerman P, Aichele P, Hengartner H, Zinkernagel RM. A functional and kinetic comparison of antiviral effector and memory cytotoxic T lymphocyte populations in vivo and in vitro. Eur J Immunol.1997;27: 3404-3413.","DOI":"10.1002\/eji.1830271240"},{"key":"2020021222024296900_REF43","doi-asserted-by":"crossref","unstructured":"Welsh RM. Assessing CD8 T cell number and dysfunction in the presence of antigen. J Exp Med.2001;193: F19-F22.","DOI":"10.1084\/jem.193.5.F19"},{"key":"2020021222024296900_REF44","doi-asserted-by":"crossref","unstructured":"Wang XZ, Stepp SE, Brehm MA, et al. Virus-specific CD8 T cells in peripheral tissues are more resistant to apoptosis than those in lymphoid organs. Immunity.2003;18: 631-642.","DOI":"10.1016\/S1074-7613(03)00116-X"},{"key":"2020021222024296900_REF45","doi-asserted-by":"crossref","unstructured":"Zinkernagel RM, Ehl S, Aichele P, et al. Antigen localisation regulates immune responses in a dose- and time-dependent fashion: a geographical view of immune reactivity. Immunol Rev.1997;156: 199-209.","DOI":"10.1111\/j.1600-065X.1997.tb00969.x"},{"key":"2020021222024296900_REF46","doi-asserted-by":"crossref","unstructured":"Meunier MC, Roy-Proulx G, Labrecque N, Perreault C. Tissue distribution of target antigen has a decisive influence on the outcome of adoptive cancer immunotherapy. Blood.2003;101: 766-770.","DOI":"10.1182\/blood-2002-04-1032"},{"key":"2020021222024296900_REF47","doi-asserted-by":"crossref","unstructured":"Hunziker L, Recher M, Macpherson AJ, et al. Hypergammaglobulinemia and autoantibody induction mechanisms in viral infections. Nat Immunol.2003;4: 343-349.","DOI":"10.1038\/ni911"},{"key":"2020021222024296900_REF48","doi-asserted-by":"crossref","unstructured":"van den Broek MF, Muller U, Huang S, Aguet M, Zinkernagel RM. Antiviral defense in mice lacking both \u03b1\/\u03b2 and \u03b3 interferon receptors. J Virol.1995;69: 4792-4796.","DOI":"10.1128\/JVI.69.8.4792-4796.1995"},{"key":"2020021222024296900_REF49","doi-asserted-by":"crossref","unstructured":"Becker C, Pohla H, Frankenberger B, et al. Adoptive tumor therapy with T lymphocytes enriched through an IFN-\u03b3 capture assay. Nat Med.2001;7: 1159-1162.","DOI":"10.1038\/nm1001-1159"},{"key":"2020021222024296900_REF50","doi-asserted-by":"crossref","unstructured":"Seaman MS, Wang CR, Forman J. MHC class Ib-restricted CTL provide protection against primary and secondary Listeria monocytogenes infection. J Immunol.2000;165: 5192-5201.","DOI":"10.4049\/jimmunol.165.9.5192"},{"key":"2020021222024296900_REF51","doi-asserted-by":"crossref","unstructured":"Das G, Sheridan S, Janeway CA Jr. The source of early IFN-\u03b3 that plays a role in Th1 priming. J Immunol.2001;167: 2004-2010.","DOI":"10.4049\/jimmunol.167.4.2004"},{"key":"2020021222024296900_REF52","doi-asserted-by":"crossref","unstructured":"Berg RE, Cordes CJ, Forman J. Contribution of CD8+ T cells to innate immunity: IFN-\u03b3 secretion induced by IL-12 and IL-18. Eur J Immunol.2002;32: 2807-2816.","DOI":"10.1002\/1521-4141(2002010)32:10<2807::AID-IMMU2807>3.0.CO;2-0"},{"key":"2020021222024296900_REF53","doi-asserted-by":"crossref","unstructured":"Pien GC, Nguyen KB, Malmgaard L, Satoskar AR, Biron CA. A unique mechanism for innate cytokine promotion of T cell responses to viral infections. J Immunol.2002;169: 5827-5837.","DOI":"10.4049\/jimmunol.169.10.5827"},{"key":"2020021222024296900_REF54","doi-asserted-by":"crossref","unstructured":"Kerksiek KM, Busch DH, Pilip IM, Allen SE, Pamer EG. H2-M3-restricted T cells in bacterial infection: rapid primary but diminished memory responses. J Exp Med.1999;190: 195-204.","DOI":"10.1084\/jem.190.2.195"},{"key":"2020021222024296900_REF55","doi-asserted-by":"crossref","unstructured":"Pe\u0301rarnau B, Saron MF, San Martin BR, et al. Single H2Kb, H2Db and double H2KbDb knockout mice: peripheral CD8+ T cell repertoire and anti-lymphocytic choriomeningitis virus cytolytic responses. Eur J Immunol.1999;29: 1243-1252.","DOI":"10.1002\/(SICI)1521-4141(199904)29:04<1243::AID-IMMU1243>3.0.CO;2-A"},{"key":"2020021222024296900_REF56","doi-asserted-by":"crossref","unstructured":"Di Rosa F, Ramaswamy S, Ridge JP, Matzinger P. On the lifespan of virgin T lymphocytes. J Immunol.1999;163: 1253-1257.","DOI":"10.4049\/jimmunol.163.3.1253"},{"key":"2020021222024296900_REF57","doi-asserted-by":"crossref","unstructured":"Tanchot C, Rocha B. Peripheral selection of T cell repertoires: the role of continuous thymus output. J Exp Med.1997;186: 1099-1106.","DOI":"10.1084\/jem.186.7.1099"},{"key":"2020021222024296900_REF58","doi-asserted-by":"crossref","unstructured":"Arstila TP, Casrouge A, Baron V, et al. A direct estimate of the human \u03b1\u03b2 T cell receptor diversity. Science.1999;286: 958-961.","DOI":"10.1126\/science.286.5441.958"},{"key":"2020021222024296900_REF59","doi-asserted-by":"crossref","unstructured":"Miller RA. The aging immune system: primer and prospectus. Science.1996;273: 70-74.","DOI":"10.1126\/science.273.5271.70"},{"key":"2020021222024296900_REF60","doi-asserted-by":"crossref","unstructured":"Miller RA, Chrisp C. T cell subset patterns that predict resistance to spontaneous lymphoma, mammary adenocarcinoma, and fibrosarcoma in mice. J Immunol.2002;169: 1619-1625.","DOI":"10.4049\/jimmunol.169.3.1619"},{"key":"2020021222024296900_REF61","doi-asserted-by":"crossref","unstructured":"Erickson M, Morkowski S, Lehar S, et al. Regulation of thymic epithelium by keratinocyte growth factor. Blood.2002;100: 3269-3278.","DOI":"10.1182\/blood-2002-04-1036"},{"key":"2020021222024296900_REF62","doi-asserted-by":"crossref","unstructured":"Poznansky MC, Evans RH, Foxall RB, et al. Efficient generation of human T cells from a tissue-engineered thymic organoid. Nat Biotechnol.2000;18: 729-734.","DOI":"10.1038\/77288"},{"key":"2020021222024296900_REF63","doi-asserted-by":"crossref","unstructured":"Rossi S, Blazar BR, Farrell CL, et al. Keratinocyte growth factor preserves normal thymopoiesis and thymic microenvironment during experimental graft-versus-host disease. Blood.2002;100: 682-691.","DOI":"10.1182\/blood.V100.2.682"},{"key":"2020021222024296900_REF64","doi-asserted-by":"crossref","unstructured":"Schmitt TM, Zuniga-Pflu\u0308cker JC. Induction of T cell development from hematopoietic progenitor cells by Delta-like-1 in vitro. Immunity.2002;17: 749-756.","DOI":"10.1016\/S1074-7613(02)00474-0"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/103\/8\/3102\/1698860\/zh800804003102.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/103\/8\/3102\/1698860\/zh800804003102.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,11]],"date-time":"2024-01-11T18:58:49Z","timestamp":1704999529000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/103\/8\/3102\/18052\/Do-thymically-and-strictly-extrathymically"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,4,15]]},"references-count":64,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2004,4,15]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2003-09-3311","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,4,15]]}}}